Analytica ramps up commercialization in the US
Brisbane based listed medical device company Analytica has appointed global medical device commercialization company SalesForce4Hire to roll out their flagship medical device known as the PeriCoach in the USA.
The Pericoach is a unique medical device that assists women to correctly exercise their pelvic floor muscles in order to reduce or eliminate Stress Urinary Incontinence, a condition that affects 1 in 3 women according to Analytica.
Stress Urinary Incontinence is generally caused by pregnancy, childbirth and menopause.
SalesForce4Hire, who’s client list include well known companies like Becton Dickinson, Alcatel-Lucent, Kimberly- Clark/Halyard Health and Gojo, specialize in creating and maintaining sales in the medical device, diagnostic and healthcare IT sectors.
They have agreed to take part of their fees in performance based Analytica share options.
Analytica CEO, Geoff Daly said, ‘This partnership is an exciting step forward for the Company and will help drive sales and awareness of PeriCoach in the US. With a solid sales team behind us, Analytica will have the capacity to focus on driving market awareness and adoption of the PeriCoach System.”
SalesForce4Hire President, Kevin Schimelfenig added: “Entering into this agreement with Analytica offers an exceptional opportunity to drive sales of its leading product PeriCoach into the women’s health category in the US market.”
The PeriCoach has been on sale in Australia and New Zealand since January, and recently launched in the UK and Ireland as the company pursues its aggressive commercialization strategy.
Analytica says the US market for incontinence pads is worth $5 billion a year and it is projected that by 2030, 5.6 million women in Australia will suffer urinary incontinence.
Closing price for the last 90 trading days
Powered by Morningstar ®